Meibomian Gland Dysfunction Clinical Trial
Official title:
Effects and Prognostic Factors of Intensive Pulse Light Treatment for Meibomian Gland Dysfunction
The investigators are going to Investigate the comparative efficacy of intense pulsed light therapy alone with that of intense pulsed light plus meibomian gland expression for meibomian gland dysfunction.
Enrolled patients are going to be randomly assigned to two groups. All of the patients will undergo four treatment sessions in total, which are two weeks apart. Group 1 will undergo two sessions of intense pulsed light therapy with meibomian gland expression, as well as two sessions of intense pulsed light alone. Group 2 will receive two sessions of intense pulsed light therapy alone, and two sessions of intense pulsed light therapy with meibomian gland expression. The following parameters will be measured at baseline, 2 weeks after the second treatment session, and 2 weeks after the fourth treatment session: tearfilm break-up time, Oxford grade for corneal staining, meibomian gland expressibility, meibum quality, and ocular surface disease index. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
| Completed |
NCT04884243 -
Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction
|
Phase 2 | |
| Active, not recruiting |
NCT04425551 -
Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction
|
N/A | |
| Terminated |
NCT02596919 -
Fast Infrared Meibography (Photography)
|
N/A | |
| Completed |
NCT01207752 -
The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
|
N/A | |
| Completed |
NCT05162261 -
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
|
N/A | |
| Recruiting |
NCT06064071 -
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
|
N/A | |
| Completed |
NCT03652051 -
A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)
|
Phase 2 | |
| Recruiting |
NCT03767530 -
Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction
|
N/A | |
| Recruiting |
NCT05577910 -
Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD
|
N/A | |
| Completed |
NCT04889950 -
Clinical Study to Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction
|
N/A | |
| Recruiting |
NCT06004895 -
Mechanisms of Light-based Therapies for Dry Eye Disease
|
N/A | |
| Completed |
NCT04147962 -
Intense Pulsed Light in Meibomian Gland Dysfunctions
|
||
| Completed |
NCT02256969 -
Intraductal Meibomian Gland Probing Trial
|
Phase 4 | |
| Recruiting |
NCT05089591 -
Intense Pulsed Light in Meibomian Gland Dysfunction
|
N/A | |
| Completed |
NCT04500821 -
Evaluation of the LipiFlow System With a New Activator
|
N/A | |
| Completed |
NCT03318874 -
Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction
|
Phase 4 | |
| Completed |
NCT06278584 -
iLux Treatment for Meibomian Gland Dysfunction
|
N/A | |
| Recruiting |
NCT04052841 -
Morphological Analysis of Meibomian Glands
|
N/A | |
| Completed |
NCT05028491 -
The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients
|